Substance anticoagulants. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy4

Blood Platelets Plasma Endothelium, Vascular Cells, Cultured

Organisms10

Sea Cucumbers Seaweed Phaeophyta Ancylostoma Strongylida Rabbits Cattle Agkistrodon Elapidae Swine

Diseases43

Thromboembolism Hemorrhage Substance-Related Disorders Thrombosis Antiphospholipid Syndrome Thrombophlebitis Venous Thrombosis Blood Coagulation Disorders Thrombophilia Venous Thromboembolism Pulmonary Embolism Activated Protein C Resistance Atrial Fibrillation Protein C Deficiency Protein S Deficiency Antithrombin III Deficiency Hematoma Lupus Erythematosus, Systemic Stroke Recurrence Hypoprothrombinemias Hemorrhagic Disorders Coagulation Protein Disorders Embolism Postoperative Hemorrhage Cerebral Hemorrhage Hematoma, Subdural Intracranial Embolism and Thrombosis Pregnancy Complications, Hematologic Disseminated Intravascular Coagulation Marijuana Abuse Alcoholism Abortion, Habitual Thrombocytopenia Cerebrovascular Disorders Sinus Thrombosis, Intracranial Intracranial Hemorrhages Pregnancy Complications, Cardiovascular Ischemic Attack, Transient Heart Diseases Intracranial Hemorrhage, Traumatic Postoperative Complications Factor V Deficiency

Chemicals and Drugs126

Anticoagulants Substance P Lupus Coagulation Inhibitor Warfarin Protein C Rodenticides Heparin Acenocoumarol Factor Xa Phenindione 4-Hydroxycoumarins Antithrombins Protein S Blood Coagulation Factors Heparin, Low-Molecular-Weight beta-Alanine Thrombomodulin Prothrombin Thrombin Vitamin K Phenprocoumon Antithrombin III Antibodies, Antiphospholipid Antibodies, Anticardiolipin Heparin Antagonists Thromboplastin Receptors, Neurokinin-1 Factor X Hirudins Factor V Coagulants beta 2-Glycoprotein I Dicumarol Factor Va Fibrinolytic Agents Platelet Aggregation Inhibitors Thiophenes Pipecolic Acids Enoxaparin Aspirin Vitamin K Epoxide Reductases Benzimidazoles Dermatan Sulfate Heparin Cofactor II Pyridones Thiobarbituric Acid Reactive Substances Cardiolipins Dalteparin Humic Substances Hazardous Substances Polysaccharides Coumarins Arthropod Proteins Citric Acid Antithrombin Proteins Tachykinins Factor VIIa Fibrin Morpholines Factor VIIIa Factor VII Neurokinin-1 Receptor Antagonists Citrates Fibrin Fibrinogen Degradation Products Phospholipids Street Drugs Heparinoids Glycoproteins Heparitin Sulfate Edetic Acid Recombinant Proteins Ancrod Chromogenic Compounds Serine Proteinase Inhibitors Neurokinin A Protein C Inhibitor Azetidines Salivary Proteins and Peptides Fibrinogen Benzylamines Heparin Lyase Receptors, Thrombin Factor IX Factor IXa Performance-Enhancing Substances Antidotes Hemostatics Annexin A5 Glycosaminoglycans Protamines Cobra Venoms Viper Venoms Factor VIII Blood Coagulation Factor Inhibitors Complement Inactivator Proteins Autoantibodies Galactans Annexins Crotalid Venoms Sulfates Chondroitin Sulfates Sulfuric Acid Esters Peptide Fragments Hexadimethrine Bromide Nadroparin 1-Carboxyglutamic Acid Receptor, PAR-1 Platelet Factor 4 Drugs, Investigational Vitamin K 1 Pyrazoles Controlled Substances Physalaemin Receptors, Cell Surface Thienopyridines Fibrinopeptide A Sulfotransferases Mixed Function Oxygenases Oligosaccharides Invertebrate Hormones Disaccharides Immunoglobulin G Receptors, Neurokinin-2 Aptamers, Nucleotide Antifibrinolytic Agents Helminth Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment40

Prothrombin Time Partial Thromboplastin Time Blood Coagulation Tests Thrombin Time International Normalized Ratio Administration, Oral Risk Factors Drug Monitoring Treatment Outcome Diagnosis, Dual (Psychiatry)Blood Preservation Blood Specimen Collection Whole Blood Coagulation Time Prospective Studies Follow-Up Studies Heart Valve Prosthesis Substance Abuse Detection Perioperative Care Retrospective Studies Bleeding Time Chromatography, High Pressure Liquid Risk Assessment Randomized Controlled Trials as Topic Hirudin Therapy Vena Cava Filters Clinical Trials as Topic Drug Therapy, Combination Oral Surgical Procedures Platelet Count Drug Administration Schedule Magnetic Resonance Spectroscopy Prevalence Thrombolytic Therapy Phlebography Incidence Drug Substitution Injections, Subcutaneous Thrombelastography Chromatography, Gel Tomography, X-Ray Computed

Psychiatry and Psychology7

Substance-Related Disorders Marijuana Abuse Alcoholism Residential Treatment Adolescent Behavior Mental Disorders Marijuana Smoking

Phenomena and Processes21

Blood Coagulation Prothrombin Time Partial Thromboplastin Time Thrombin Time Hemostasis Time Factors Dose-Response Relationship, Drug Fibrinolysis Whole Blood Coagulation Time Drug Interactions Bleeding Time Kinetics Pregnancy Structure-Activity Relationship Platelet Activation Protein Binding Platelet Aggregation Amino Acid Sequence Platelet Count Molecular Weight Binding Sites

Disciplines and Occupations1

Anthropology, Education, Sociology and Social Phenomena2

Drug and Narcotic Control United States Substance Abuse and Mental Health Services Administration

Technology, Industry, Agriculture1

Hexadimethrine Bromide

Information Science4

Molecular Sequence Data Amino Acid Sequence Prevalence Incidence

Health Care19

Substance Abuse Treatment Centers Rodent Control Risk Factors Treatment Outcome Prospective Studies Follow-Up Studies Substance Abuse Detection Perioperative Care Retrospective Studies Risk Assessment Randomized Controlled Trials as Topic Comorbidity Drug and Narcotic Control Clinical Trials as Topic Age Factors Prevalence Incidence Drug Substitution United States Substance Abuse and Mental Health Services Administration

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Health Care Geographicals

Anticoagulants Substance P Lupus Coagulation Inhibitor Warfarin Blood Coagulation Prothrombin Time Protein C Partial Thromboplastin Time Rodenticides Heparin Acenocoumarol Factor Xa Phenindione 4-Hydroxycoumarins Antithrombins Blood Coagulation Tests Thrombin Time International Normalized Ratio Thromboembolism Protein S Blood Coagulation Factors Hemorrhage Substance-Related Disorders Heparin, Low-Molecular-Weight beta-Alanine Thrombomodulin Thrombosis Prothrombin Thrombin Antiphospholipid Syndrome Vitamin K Thrombophlebitis Phenprocoumon Venous Thrombosis Antithrombin III Antibodies, Antiphospholipid Administration, Oral Antibodies, Anticardiolipin Blood Coagulation Disorders Thrombophilia Venous Thromboembolism Pulmonary Embolism Heparin Antagonists Thromboplastin Receptors, Neurokinin-1 Factor X Substance Abuse Treatment Centers Hirudins Factor V Coagulants beta 2-Glycoprotein I Dicumarol Activated Protein C Resistance Hemostasis Atrial Fibrillation Factor Va Fibrinolytic Agents Platelet Aggregation Inhibitors Thiophenes Rodent Control Pipecolic Acids Enoxaparin Aspirin Vitamin K Epoxide Reductases Protein C Deficiency Benzimidazoles Dermatan Sulfate Heparin Cofactor II Pyridones Time Factors Protein S Deficiency Thiobarbituric Acid Reactive Substances Risk Factors Cardiolipins Antithrombin III Deficiency Hematoma Drug Monitoring Dalteparin Treatment Outcome Humic Substances Hazardous Substances Polysaccharides Sea Cucumbers Coumarins Lupus Erythematosus, Systemic Dose-Response Relationship, Drug Stroke Arthropod Proteins Diagnosis, Dual (Psychiatry)Citric Acid Recurrence Hypoprothrombinemias Antithrombin Proteins Tachykinins Factor VIIa Hemorrhagic Disorders Fibrin Seaweed Morpholines Factor VIIIa

No FAQ available that match "substance anticoagulants"